Drug Shortage Report for TARO-TERCONAZOLE
Report ID | 102344 |
Drug Identification Number | 02247651 |
Brand name | TARO-TERCONAZOLE CREAM |
Common or Proper name | TERCONAZOLE CREAM |
Company Name | TARO PHARMACEUTICALS INC |
Market Status | MARKETED |
Active Ingredient(s) | TERCONAZOLE |
Strength(s) | 0.4% |
Dosage form(s) | CREAM |
Route of administration | VAGINAL |
Packaging size | 45 g |
ATC code | G01AG |
ATC description | ANTIINFECTIVES/ANTISEPT.,EXCL COMB WITH CORTICOST. |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2019-12-27 |
Estimated end date | 2020-01-31 |
Actual end date | 2020-01-10 |
Shortage status | Resolved |
Updated date | 2020-01-13 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 130 EAST DRIVE BRAMPTON, ONTARIO CANADA L6T 1C1 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2020-01-13 | French | Compare |
v3 | 2020-01-13 | English | Compare |
v2 | 2020-01-04 | French | Compare |
v1 | 2020-01-04 | English | Compare |
Showing 1 to 4 of 4